Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)
Kandai Nozu(Kobe Children's Hospital), Kazumoto Iijima(Kobe Children's Hospital), Hidefumi Nakamura(National Center For Child Health and Development), Tamaki Morohashi(Hokkaido University Hospital), Yoko Ohwada(Dokkyo Medical University), Koichi Nakanishi(University of the Ryukyus), Tomoyuki Sakai(Tokyo Metropolitan Children's Medical Center), Hiroshi Kaito(Kobe University), Akihide Konishi, Yuko Shima(Wakayama Medical University), Yasufumi Ohtsuka(Saga University), Masafumi Oka(Saga University), Shuichi Ito(Yokohama City University), Aya Inaba(Yokohama City University Medical Center), Seiji Tanaka(Kurume University Medical Center), Kenji Ishikura(Kitasato University), Tomoko Horinouchi(Kobe University), Koichi Kamei(National Center For Child Health and Development), Takashi Omori(Kyoto University), Mayumi Sako(National Center For Child Health and Development), Yuji Kano, Riku Hamada
Cited by 6
Related Papers
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149